✦ LIBER ✦

The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying theCYP2C19*17 variant

✍ Scribed by Christina Justenhoven; Ofure Obazee; Stefan Winter; Fergus J. Couch; Janet E. Olson; Per Hall; Ulf Hannelius; Jingmei Li; Keith Humphreys; Gianluca Severi; Graham Giles; Melissa Southey; Laura Baglietto; Peter A. Fasching; Matthias W. Beckmann; Arif B. Ekici; Ute Hamann; Christian Baisch; Volker Harth; Sylvia Rabstein; Anne Lotz; Beate Pesch; Thomas Brüning; Yon-Dschun Ko; Hiltrud Brauch

Publisher: Springer US
Year: 2011
Tongue: English
Weight: 169 KB
Volume: 131
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-011-1827-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Polymorphisms in theBRCA1andABCB1genes m

Polymorphisms in theBRCA1andABCB1genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women

✍ The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone The 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 193 KB

Genetic polymorphisms in phase I and pha

Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women

✍ The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone The 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 203 KB

Erratum to: Genetic polymorphisms in pha

Erratum to: Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women

✍ The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone The 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 54 KB